VCU study suggests antimicrobial scrubs may reduce bacteria

May also help decrease risk of MRSA transmission to patients

 

Richmond, Va., USA (January 19, 2012) –– The use of antimicrobial impregnated scrubs combined with good hand hygiene is effective in reducing the burden of Methicillin-Resistant Staphylococcus Aureus (MRSA) on healthcare workers’ apparel and may potentially play a role in decreasing the risk of MRSA transmission to patients, according to a new study from Virginia Commonwealth University researchers.

 

Previous findings have shown that hospital textiles may contribute to the transmission of pathogens through indirect contact via the hands of hospital staff and that antimicrobial textiles may reduce the bioburden, or the number of bacteria living on a surface before sterilization in clinical settings.

 

Led by Gonzalo Bearman, M.D.,M.P.H., associate professor of internal medicine in the VCU School of Medicine and associate hospital epidemiologist at the VCU Medical Center, the study "A Crossover Trial of Antimicrobial Scrubs to Reduce Methicillin-Resistant Staphylococcus Aureus Burden on Healthcare Worker Apparel," is currently available online and will appear in the March issue of the journal Infection Control and Hospital Epidemiology, the official publication of the Society for Healthcare Epidemiology of America.

 

"We strive to study infection prevention interventions that are simple yet effective for the reduction of healthcare associated infections," said Bearman. "The goal is to affect change or implement risk reduction by methods that are both easily implemented and sustained."

 

In the study, 32 healthcare workers wore four pairs of identically appearing control scrubs and study scrubs impregnated with an antimicrobial, or germ-killing, compound over the course of four months, washing them regularly. Participants also received identical hand hygiene educational sessions every four weeks, and researchers assessed compliance with hand hygiene practices.

 

Researchers conducted once weekly, unannounced, garment and hand cultures of participants at the start and end of each shift where they obtained two samples from the garment’s abdominal area and cargo pant pocket – two areas of high touch and high bacterial colonization.

 

According to Bearman, although the scrubs did not impact the degree of MRSA on the healthcare workers’ hands, the antimicrobial scrubs were effective in reducing the burden of MRSA on healthcare worker apparel.

 

"It is critical for healthcare workers and patients to understand that the environment—including inanimate surfaces and apparel – is not sterile, and is frequently a reservoir of drug resistant bacteria," said Bearman. "Meticulous hand hygiene at the point of patient care is critical for reducing the risk of a hospital acquired infection.

 

"If widespread antimicrobial scrub use were added to existing infection prevention strategies, a further decrease in hospital acquired infections may occur by limiting the cross transmission of pathogens via apparel. The actual impact of antimicrobial scrubs on hospital acquired infections needs further study," he said.

 

 

The scrubs tested in the study were manufactured by Vestagen Technical Textiles.

 

Bearman collaborated with VCU researchers Kakotan Sanogo, Michael P. Stevens, M.D., Curtis Sessler, M.D., Richard Wenzel, M.D., along with Adriana Rosato, Ph.D., Methodist Hospital Research Institute and Kara Elam, doctoral student, University of Mississippi.

 

To view the complete study, visit http://www.jstor.org/stable/10.1086/664045

 

About VCU and the VCU Medical Center: Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 31,000 students in 211 certificate and degree programs in the arts, sciences and humanities. Sixty-nine of the programs are unique in Virginia, many of them crossing the disciplines of VCU’s 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation’s leading academic medical centers. For more, see http://www.vcu.edu

 


 

Virginia Commonwealth University, 19.01.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung